All Stories

  1. ZIF-8 with encapsulated dihydroartemisinin in a drug delivery system for protection against Plasmodium berghei ANKA-induced experimental cerebral malaria in C57BL/6N mice
  2. Prevalence and risk factors evaluation for transfusion-transmissible infections among blood donors from Shiyan, China
  3. Seroprevalence and Risk Factors of Transfusion‐Related Infections Among Blood Donors in Central China During and After the COVID‐19 Pandemic
  4. Rapid detection of mutations in the suspected piperaquine resistance gene E415G-exo in Plasmodium falciparum exonuclease via AS‒PCR and RAA with CRISPR/Cas12a
  5. Rapid and supersensitive allele detection of Plasmodium falciparum chloroquine resistance via a Pyrococcus furiosus argonaute-triggered dual-signal biosensing platform
  6. Recognition of parasitic helminth eggs via a deep learning-based platform
  7. Establishment and evaluation of a qPCR method for the detection of pfmdr1 mutations in Plasmodium falciparum, the causal agent of fatal malaria
  8. An insight into the gut microbiota after Schistosoma japonicum eggs immunization in an experimental ulcerative colitis model
  9. Inhibition of the RLR signaling pathway by SARS-CoV-2 ORF7b is mediated by MAVS and abrogated by ORF7b-homologous interfering peptide
  10. Inhibition of SARS-CoV-2 replication by a ssDNA aptamer targeting the nucleocapsid protein
  11. Erratum for Liu et al., “Ubiquitination of SARS-CoV-2 ORF7a Prevents Cell Death Induced by Recruiting BclXL To Activate ER Stress”
  12. Chromosome-level genome assembly, reannotation and decoding of a Trichomonas vaginalis clinical isolate from Shiyan, Central China
  13. The Interaction between SARS-CoV-2 Nucleocapsid Protein and UBC9 Inhibits MAVS Ubiquitination by Enhancing Its SUMOylation
  14. The Interaction between SARS-CoV-2 Nucleocapsid Protein and UBC9 Inhibits MAVS Ubiquitination by Enhancing Its SUMOylation
  15. Rapid and Ultrasensitive Detection of Plasmodium spp. Parasites via the RPA-CRISPR/Cas12a Platform
  16. Transcriptional profile of Trichomonas vaginalis in response to metronidazole
  17. Editorial: Innovative tools to support the elimination of neglected tropical diseases (NTDs)
  18. Insight into molecular diagnosis for antimalarial drug resistance of Plasmodium falciparum parasites: A review
  19. Additive Therapy of Plasmodium berghei-Induced Experimental Cerebral Malaria via Dihydroartemisinin Combined with Rapamycin and Atorvastatin
  20. Detection of Antimalarial Resistance-Associated Mutations in Plasmodium falciparum via a Platform of Allele-Specific PCR Combined with a Gold Nanoparticle-Based Lateral Flow Assay
  21. Ubiquitination of SARS-CoV-2 ORF7a Prevents Cell Death Induced by Recruiting BclXL To Activate ER Stress
  22. Deficiency of migration inhibitory factor influences the gut microbiota of C57BL/6 mice infected with Plasmodium berghei ANKA
  23. Cerebral malaria induced by plasmodium falciparum: clinical features, pathogenesis, diagnosis, and treatment
  24. Single-nucleotide polymorphisms of artemisinin resistance-related pfubp1 and pfap2mu genes in imported Plasmodium falciparum to Wuhan, China
  25. Molecular Surveillance of Artemisinin-Based Combination Therapies Resistance in Plasmodium falciparum Parasites from Bioko Island, Equatorial Guinea
  26. A Rapid and Specific Genotyping Platform for Plasmodium falciparum Chloroquine Resistance via Allele-Specific PCR with a Lateral Flow Assay
  27. Observation of the Gut Microbiota Profile in BALB/c Mice Induced by Plasmodium yoelii 17XL Infection
  28. Vaccines as a Strategy to Control Trichinellosis
  29. Platelets are highly efficient and efficacious carriers for tumor-targeted nano-drug delivery
  30. Ferroptosis triggered by dihydroartemisinin facilitates chlorin e6 induced photodynamic therapy against lung cancer through inhibiting GPX4 and enhancing ROS
  31. A Nanodrug Coated with Membrane from Brain Microvascular Endothelial Cells Protects against Experimental Cerebral Malaria
  32. Observation of the Gut Microbiota Profile in C57BL/6 Mice Induced by Plasmodium berghei ANKA Infection
  33. SARS-CoV-2 Accessory Protein ORF7b Mediates Tumor Necrosis Factor-α-Induced Apoptosis in Cells
  34. Molecular surveillance of anti-malarial resistance pfcrt, pfmdr1, and pfk13 polymorphisms in African Plasmodium falciparum imported parasites to Wuhan, China
  35. Genetic diversity and natural selection on the thrombospondin-related adhesive protein (TRAP) gene of Plasmodium falciparum on Bioko Island, Equatorial Guinea and global comparative analysis
  36. Multiple Single-Nucleotide Polymorphism Detection for Antimalarial Pyrimethamine Resistance via Allele-Specific PCR Coupled with Gold Nanoparticle-Based Lateral Flow Biosensor
  37. Reverse Transcription Recombinase-Aided Amplification Assay With Lateral Flow Dipstick Assay for Rapid Detection of 2019 Novel Coronavirus
  38. Molecular surveillance of anti-malarial resistance Pfdhfr and Pfdhps polymorphisms in African and Southeast Asia Plasmodium falciparum imported parasites to Wuhan, China
  39. Molecular epidemiological surveillance of Africa and Asia imported malaria in Wuhan, Central China: comparison of diagnostic tools during 2011–2018
  40. Cloning and identification of a new multifunctional Ascaris-type peptide from the hemolymph of Buthus martensii Karsch
  41. Genetic polymorphism of Plasmodium falciparum circumsporozoite protein on Bioko Island, Equatorial Guinea and global comparative analysis
  42. Epidemiological and Clinical Characteristics of Patients With Coronavirus Disease-2019 in Shiyan City, China
  43. <p>Trends in Molecular Markers Associated with Resistance to Sulfadoxine-Pyrimethamine (SP) Among <em>Plasmodium falciparum</em> Isolates on Bioko Island, Equatorial Guinea: 2011–2017</p>
  44. Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS‐CoV‐2
  45. Immune cells within the tumor microenvironment: Biological functions and roles in cancer immunotherapy
  46. Analysis of Plasmodium falciparum Na+/H+ exchanger (pfnhe1) polymorphisms among imported African malaria parasites isolated in Wuhan, Central China
  47. Corrigendum: Alterations of the Mice Gut Microbiome via Schistosoma japonicum Ova-Induced Granuloma
  48. High prevalence of Pfdhfr–Pfdhps quadruple mutations associated with sulfadoxine–pyrimethamine resistance in Plasmodium falciparum isolates from Bioko Island, Equatorial Guinea
  49. Alterations of the Mice Gut Microbiome via Schistosoma japonicum Ova-Induced Granuloma
  50. Genetic diversity and allele frequencies of Plasmodium falciparum msp1 and msp2 in parasite isolates from Bioko Island, Equatorial Guinea
  51. Programmed cell death protein 4 deficiency suppresses foam cell formation by activating autophagy in advanced glycation end‐product low‐density lipoprotein–induced macrophages
  52. Bldesin, the first functionally characterized pathogenic fungus defensin with Kv1.3 channel and chymotrypsin inhibitory activities
  53. The Kv1.3 channel-inhibitory toxin BF9 also displays anticoagulant activity via inhibition of factor XIa
  54. Surveillance of Genetic Variations Associated with Antimalarial Resistance ofPlasmodium falciparumIsolates from Returned Migrant Workers in Wuhan, Central China
  55. Development of loop-mediated isothermal amplification with Plasmodium falciparum unique genes for molecular diagnosis of human malaria
  56. Discovery of three toxin peptides with Kv1.3 channel and IL-2 cytokine-inhibiting activities from Non-Buthidae scorpions, Chaerilus tricostatus and Chaerilus tryznai
  57. St20, a new venomous animal derived natural peptide with immunosuppressive and anti-inflammatory activities
  58. Prevalence of HIV and malaria: a cross-sectional study on Bioko Island, Equatorial Guinea
  59. Arctigenin inhibits STAT3 and exhibits anticancer potential in human triple-negative breast cancer therapy
  60. Plasmodium vivax GPI-anchored micronemal antigen (PvGAMA) binds human erythrocytes independent of Duffy antigen status
  61. Seroprevalence of human immunodeficiency virus, hepatitis B and C viruses, and Treponema pallidum infections among blood donors at Shiyan, Central China
  62. Cucurbitacin B reverses multidrug resistance by targeting CIP2A to reactivate protein phosphatase 2A in MCF-7/Adriamycin cells
  63. Limited artemisinin resistance-associated polymorphisms in Plasmodium falciparum K13-propeller and PfATPase6 gene isolated from Bioko Island, Equatorial Guinea
  64. Taenia saginata Infestation
  65. Molecular mutation profile of Pfcrt and Pfmdr1 in Plasmodium falciparum isolates from Bioko Island, Equatorial Guinea
  66. A new Kunitz-type plasmin inhibitor from scorpion venom
  67. Seroprevalence of Human Immunodeficiency Virus, Hepatitis B Virus, Hepatitis C Virus, and Treponema pallidum Infections among Blood Donors on Bioko Island, Equatorial Guinea
  68. Identification of Immunodominant B-cell Epitope Regions of Reticulocyte Binding Proteins in <i>Plasmodium vivax</i> by Protein Microarray Based Immunoscreening
  69. Antigenicity and immunogenicity of PvRALP1, a novel Plasmodium vivax rhoptry neck protein
  70. In silicoanalysis for structure, function and T-cell epitopes of a hypothetical conserved (HP-C) protein coded by PVX_092425 inPlasmodium vivax
  71. High prevalence of pfmdr1 N86Y and Y184F mutations inPlasmodium falciparumisolates from Bioko island, Equatorial Guinea
  72. Profiling the humoral immune responses to Plasmodium vivax infection and identification of candidate immunogenic rhoptry-associated membrane antigen (RAMA)
  73. The Plasmodium vivax Merozoite Surface Protein 1 Paralog Is a Novel Erythrocyte-Binding Ligand of P. vivax
  74. Identification and characterization of the Plasmodium falciparum RhopH2 ortholog in Plasmodium vivax
  75. Dissection of the Plasmodium vivax reticulocyte binding-like proteins (PvRBPs)
  76. Pv12, a 6-Cys antigen of Plasmodium vivax, is localized to the merozoite rhoptry